Guidelines for Poster Preparation
Thank you for considering to present your work as a poster at DrugDesign2012.
Please prepare your poster in A1 portrait format (59cm wide x 84cm long). Please do not laminate your poster. Further information about poster sizes can be found on the following link:
http://tinyurl.com/y7bf
Posters will be displayed for the full duration of the conference. Please shadow your posters during break times to answer any questions.
Posters larger than A1 will only be displayed subject to the availability of space.
Please ensure you have appropriate permissions for the publication of your abstract from the original copyright holders. Should you wish your abstract not to be published, please notify us in writing at the time of abstract submission.
Invitation to submit full papers: Accepted abstracts are invited to submit full manuscripts to the Journal of Molecular and Genetic Medicine. The deadline for sending full manuscripts is 30 October 2012. The conference will cover the basic open-access publication charges of accepted manuscripts.
Titles of accepted poster abstracts will be displayed below.
Accepted Posters
(Presenters in Bold)
If your poster abstract is not listed below please contact us as soon as possible.
From Gene to Hit: Identification of Aldehyde Dehydrogenase 1A1 modulators Using Virtual Screening
Cédric Chauvignac, Diego Pallares, Vinayaka Kotraiah, Deanna Toema, Dehe Kong, Eric Beausoleil
Exonhit, 63 Bld Masséna, 75013 Paris, France
Structure-based inhibitor design for Trypanosoma brucei aldolase
Leonardo Luiz Gomes Ferreira and Adriano Defini Andricopulo
Laboratório de Química Medicinal e Computacional, Universidade de São Paulo, São Carlos-SP, Brazil
Identification of Blocker Binding Site and Critical Chemical Features for TREK-2 Potassium Channel by Molecular Docking Simulation and Structure- Based Pharmacophore Modeling
Songmi Kim, Yuno Lee, and Keun Woo Lee
Gyeongsang National University, South Korea
Oral Polo-Like Kinase (PLK) inhibitors with enhanced selectivity obtained using residue targeted design
Ronald Knegtel, Jean-Damien Charrier, Kieron Brown, Steven Durrant, Matthew Griffiths, Catherine Hudson, Dave Kay, Michael O’Donnell, Fran çoi se Pierard, Heather Twin, Peter Weber and Stephen Young
Vertex Pharmaceuticals (Europe) Ltd, Milton Park, OXON, UK
Identification of Blocker Binding Site in Mouse TRESK Potassium Channel by Molecular Modeling Study
Songmi Kim, Yuno Lee, and Keun Woo Lee
Gyeongsang National University, South Korea
Combined approach of Molecular Docking and Molecular Dynamics Simulations for Stilbene Derivatives as a Novel and Competitive Class of α-Glucosidase Inhibitors
Yuno Lee, Songmi Kim, and Keun Woo Lee
Gyeongsang National University, South Korea
Small molecule library screening for the selection of novel Staphylococcus aureus sortase A inhibitors
Dmitrijs Žuļenkovs and Ainārs Leončiks
Biomedical Research and Study Centre, Ratsupites 1, Riga, LV1067, Latvia
